Quick Answer
BioScience Health Innovations, Inc. reported Operating Income of $719.1 thousand for fiscal year 2025.
BioScience Health Innovations, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $719.1K | +726.5% |
| 2024 | $87.0K | +134.6% |
| 2023 | -$251.5K | -47.6% |
| 2022 | -$170.4K | -85.4% |
| 2022 | -$91.9K | -258.9% |
| 2021 | -$25.6K | -233.4% |
| 2020 | -$7.7K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.8K | -115.6% | -101.9% |
| June 30, 2025 | $457.7K | +516.7% | +7.2% |
| March 31, 2025 | $426.8K | +899.5% | +659.4% |
| September 30, 2024 | $56.2K | +198.3% | -24.3% |
| June 30, 2024 | $74.2K | +187.1% | +239.0% |
| March 31, 2024 | -$53.4K | +24.5% | +6.6% |
| September 30, 2023 | -$57.1K | +32.5% | +33.0% |
| June 30, 2023 | -$85.3K | — | -20.6% |
- BioScience Health Innovations, Inc. showed an increase of +726.5% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, BioScience Health Innovations, Inc.’s operating income has grown by 9460.2% (from -$7.7 thousand to $719.1 thousand).
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: